Julia D. Maltzman's most recent trade in Adicet Bio Inc was a trade of 750,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 31, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Adicet Bio Inc | Julia D. Maltzman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 750,000 | 750,000 | - | - | Stock Option (Right to Buy) |